Concepedia

Author

Somaieh Hedayat

Institute of Cancer ResearchORCID

Also Known As

S. Hedayat, Somaieh Hedayat

66

Publications

2.9K

Citations

16

H-Index

13

Concepts

All Affiliations

Institute of Cancer ResearchUniversity of PaduaCancer Research UKRoyal Marsden NHS Foundation TrustRoyal Marsden Hospital
SH

About

Somaieh Hedayat is an author at Institute of Cancer Research specializing in cell signaling, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

28

2

Natural Sciences

1

1

28

3

Biochemistry

1

1

28

4

Cell Biology

1

1

28

5

Molecular Biology

1

1

28

Somaieh Hedayat

×

14

Publications

2.8K

Citations

14

H-Index

YearCitations

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

Georgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou,

Science

2018

1.9K

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial

Khurum Khan, David Cunningham, Benjamin Werner,

Cancer Discovery

2018

233

MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma

Andrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis,

Gastroenterology

2017

111

Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells

Roberta Ferraldeschi, Jonathan Welti, Marissa Powers,

Cancer Research

2016

90

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study

Khurum Khan, Mihaela Rata, David Cunningham,

Gut

2017

70

HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells

Kamolporn Amornsupak, Suyanee Thongchot, Chanida Thinyakul,

BMC Cancer

2022

58

HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target

Jacqueline H. L. Fok, Somaieh Hedayat, Lei Zhang,

Clinical Cancer Research

2018

56

miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial

Gayathri Anandappa, Andrea Lampis, David Cunningham,

Clinical Cancer Research

2019

45

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

Elizabeth Smyth, Georgios Vlachogiannis, Somaieh Hedayat,

Gut

2020

41

Modulation of Biliary Cancer Chemo‐Resistance Through MicroRNA‐Mediated Rewiring of the Expansion of CD133+ Cells

Pietro Carotenuto, Somaieh Hedayat, Matteo Fassan,

Hepatology

2019

39

Page 1